Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1986 Jun;62(3):177–180. doi: 10.1136/sti.62.3.177

Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.

J N Weber, A McCreaner, E Berrie, J Wadsworth, D J Jeffries, A J Pinching, J R Harris
PMCID: PMC1011932  PMID: 3015772

Abstract

Fifty four sexual partners of homosexual men with the acquired immune deficiency syndrome (AIDS) were studied, of whom 32 were seropositive and 22 seronegative for human T cell lymphotropic virus type III or lymphadenopathy virus (HTLV-III/LAV) antibody, which showed that repeated exposure by anal intercourse does not necessarily lead to seroconversion. Seropositivity to HTLV-III/LAV was not associated with the absolute number of sexual partners, receptive anal intercourse, or the use of recreational drugs, but was associated with a history of other sexually transmitted diseases (STDs), particularly in the year preceding the patient's initial examination. Acquisition of an STD after the date of last sexual contact with a person with AIDS was strongly associated (p less than 0.001) with the development of persistent generalised lymphadenopathy (PGL). Concurrent or recent STDs would seem to be an important cofactor in developing antibody to HTLV-III/LAV and in the progression of infection from a person being asymptomatic to having PGL.

Full text

PDF
177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broder S., Gallo R. C. A pathogenic retrovirus (HTLV-III) linked to AIDS. N Engl J Med. 1984 Nov 15;311(20):1292–1297. doi: 10.1056/NEJM198411153112006. [DOI] [PubMed] [Google Scholar]
  2. Brun-Vezinet F., Rouzioux C., Barre-Sinoussi F., Klatzmann D., Saimot A. G., Rozenbaum W., Christol D., Gluckmann J. C., Montagnier L., Chermann J. C. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet. 1984 Jun 9;1(8389):1253–1256. doi: 10.1016/s0140-6736(84)92444-9. [DOI] [PubMed] [Google Scholar]
  3. Cheingsong-Popov R., Weiss R. A., Dalgleish A., Tedder R. S., Shanson D. C., Jeffries D. J., Ferns R. B., Briggs E. M., Weller I. V., Mitton S. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet. 1984 Sep 1;2(8401):477–480. doi: 10.1016/s0140-6736(84)92562-5. [DOI] [PubMed] [Google Scholar]
  4. Gazzard B. G., Shanson D. C., Farthing C., Lawrence A. G., Tedder R. S., Cheingsong-Popov R., Dalgleish A., Weiss R. A. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Lancet. 1984 Sep 1;2(8401):480–483. doi: 10.1016/s0140-6736(84)92563-7. [DOI] [PubMed] [Google Scholar]
  5. Goedert J. J., Sarngadharan M. G., Biggar R. J., Weiss S. H., Winn D. M., Grossman R. J., Greene M. H., Bodner A. J., Mann D. L., Strong D. M. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet. 1984 Sep 29;2(8405):711–716. doi: 10.1016/s0140-6736(84)92624-2. [DOI] [PubMed] [Google Scholar]
  6. Jones P., Hamilton P. J., Bird G., Fearns M., Oxley A., Tedder R., Cheingsong-Popov R., Codd A. AIDS and haemophilia: morbidity and morality in a well defined population. Br Med J (Clin Res Ed) 1985 Sep 14;291(6497):695–699. doi: 10.1136/bmj.291.6497.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Laurence J., Brun-Vezinet F., Schutzer S. E., Rouzioux C., Klatzmann D., Barré-Sinoussi F., Chermann J. C., Montagnier L. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med. 1984 Nov 15;311(20):1269–1273. doi: 10.1056/NEJM198411153112001. [DOI] [PubMed] [Google Scholar]
  8. Melbye M., Biggar R. J., Ebbesen P., Sarngadharan M. G., Weiss S. H., Gallo R. C., Blattner W. A. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) 1984 Sep 8;289(6445):573–575. doi: 10.1136/bmj.289.6445.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Safai B., Sarngadharan M. G., Groopman J. E., Arnett K., Popovic M., Sliski A., Schüpbach J., Gallo R. C. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet. 1984 Jun 30;1(8392):1438–1440. doi: 10.1016/s0140-6736(84)91933-0. [DOI] [PubMed] [Google Scholar]
  10. Salahuddin S. Z., Groopman J. E., Markham P. D., Sarngadharan M. G., Redfield R. R., McLane M. F., Essex M., Sliski A., Gallo R. C. HTLV-III in symptom-free seronegative persons. Lancet. 1984 Dec 22;2(8417-8418):1418–1420. doi: 10.1016/s0140-6736(84)91619-2. [DOI] [PubMed] [Google Scholar]
  11. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES